Abstract
The aim of the study was to report on the clinical utility of naturalistic adjunctive treatment with valproate (VPA) in a group of panic disorder (PD) patients with comorbid bipolar disorder (BD) or otherwise resistant to antidepressants. The hypothesis was that these patients might not respond because of coexisting low-grade mood instability and adjunctive VPA treatment might ameliorate PD symptoms. A group of 47 patients with lifetime comorbid BD (n = 35, 74.5%) or otherwise resistant to antidepressants (n = 12, 25.6%), from a population of 326 consecutive outpatients with PD-Agoraphobia evaluated and treated at the Psychiatric Institute of the University of Pisa from 1991 to 1995, and followed for a period of 3 years. All patients were evaluated at baseline and at least every 2 months by means of an intensive interview including semi-structured and structured instruments (SCID, Life-Up, and Panic Disorder/Agoraphobia Interview). Mean dosage was 687 (SD = 234) mg/day (min 400, max 1,500 mg/day). Adjunctive treatment with VPA was well tolerated by all subjects, and there was no treatment interruption because of side effects or adverse events. All antidepressants-resistant subjects and 31 of 35 (88.6%) patients with bipolar comorbidity achieved symptomatological remission. During the observation period, 7 (58.3%) among resistant subjects and 17 (48.6%) of bipolar patients had a relapse of panic disorder after remission. Survival analysis of remission durations and onset relapses for PD and Agoraphobia did not show significant differences between the two groups. Relapses of Agoraphobia were less frequent and more delayed than those for panic. According to the results, VPA seems to be an effective and a well-tolerated adjunctive treatment in PD patients who were resistant to antidepressant therapy or had BD in comorbidity. The results of the study support the hypothesis of resistance to antidepressant treatment being related to mood instability.
Similar content being viewed by others
References
Savino M, Perugi G, Simonini E, Soriani A, Cassano GB, Akiskal HS (1993) Affective comorbidity in panic disorder: is there a bipolar connection? J Affect Disord 28:155–163
Bowen R, South M, Hawkes J (1994) Mood swings in patients with panic disorder. Can J Psychiatry 39(2):91–94
Grunhaus L, Pande AC, Brown MB, Greden JF (1994) Clinical characteristics of patients with concurrent major depressive disorder and panic disorder. Am J Psychiatry 151(4):541–546
Freeman MP, Freeman SA, McElroy SL (2002) The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology and treatment issues. J Affect Disord 68(1):1–23
Angold A, Costello EJ (1995) Developmental epidemiology. Epidemiol Rev 17(1):74–82
Chen YW, Dilsaver SC (1995) Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey. Am J Psychiatry 152(2):280–282
Shoaib AM, Dilsaver SC (1994–1995) Panic disorder in subjects with pure mania and depressive mania. Anxiety 1(6):302–304
Dilsaver SC, Chen YW, Swann AC, Shoaib AM, Tsai-Dilsaver Y, Krajewski KJ (1997) Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res 14(73):47–56
Craig T, Hwang MY, Bromet EJ (2002) Obsessive-compulsive and panic symptoms in patients with first-admission psychosis. Am J Psychiatry 159(4):592–598
MacKinnon DF, McMahon FJ, Simpson SG (1997) Panic Disorder with familial bipolar disorder. Biol Psychiatry 42:90–95
MacKinnon DF, Zandi PP, Cooper J (2002) Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry 159:30–35
Feske U, Frank E, Mallinger AG (2000) Anxiety as a correlate of response to the Acute Treatment of Bipolar I Disorder. Am J Psychiatry 157:956–962
Van Scheyen JD, van Kammen DP (1979) Clomipramine-induced mania in unipolar depression. Arch Gen Psychiatry 36(5):560–565
Rhimer Z, Barsi J, Belso N (1996) Antidepressant induced hypomania in obsessive-compulsive disorder. Int Clin Psychopharm 11:203–205
Himmelhoch JM (1998) Social anxiety, hypomania and the bipolar spectrum: Data, theory and clinical issues. J Affect Disord 50:203–213
Levy D, Kimhi R, Barak Y, Aviv A, Elizur A (1998) Antidepressant-associated mania: a study of anxiety disorders patients. Psychopharmacology 136(3):243–246
Van Putten T, Marder SR (1987) Behavioral toxicity of antipsychotic drugs. J Clin Psychiatry 48(1):13–19
Argyle N (1990) Panic attacks in chronic schizophrenia. Br J Psychiatry 177:430–433
Baker R, Chengappa KN, Baird JW (1992) Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry 53(12):439–442
de Haan L, Beuk N, Hoogenboom B (1997) Obsessive-compulsive symptoms during treatment with olanzapine and risperidone : a prospective study of 113 patients with recent-onset schizophrenia or related disorders. J Clin Psychiatry 58:119–122
Uhde TW, Post RM (1984) Carbamazepine in the treatment of neuropsychiatric disorder. In: Emrich HM (ed) Anticonvulsants in the treatment of affective illness. Excerpta Medica, Almere
Edlund MJ, Swann AC, Clothier J (1987) Patients with panic attacks and abnormal EEG results. Am J Psychiatry 144:508–509
Primeau F, Fontaine R, Beauclair L (1990) Valproic acid and panic disorder. Can J Psychiatry 35:248–250
Lum M, Fontaine R, Elie R (1991) Probable interaction of sodium valproate with benzodiazepines. Prog Neuropsychopharmacol Biol Psychiatry 15:269–273
Woodman CL, Noyes R (1994) Panic Disorder: treatment with valproate. J Clin Psychiatry 55:134–136
Keck PE, Taylor VE, Tugrul KC (1993) Valproate treatment of panic disorder and lactate-induced panic attacks. Biol Psychiatry 33:542–546
Baetz M, Bowen RC (1998) Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy. Can J Psychiatry 43(1):73–77
Akiskal HS, Mallya G (1987) Criteria for the “soft” bipolar spectrum: treatment implications. Psychopharmacol Bull 23(1):68–73
Toni C, Cassano GB, Perugi G, Murri L, Mancino M, Petracca A et al. (1996) Psychosensorial and related phenomena in panic disorder and in temporal lobe epilepsy. Comprehensive Psychiatry 37(2)
Keller M, Lavori P, Friedman B (1987) The longitudinal Interval Follow-up Evaluation. A Comprehensive Method for assessing outcome in perspective longitudinal studies. Arch Gen Psychiatry 44:540–548
Katschnig H, Amering M, Stolk JM (1995) Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry 167:487–494
Guy W (1976) Adult Personal Data Inventory. In: Guy W (ed) ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, pp 93–107
Andreasen NC, Endicott J, Spitzer RL, Winokur G (1977) The family history method using diagnostic criteria. Arch Gen Psychiatry 34(10):1229–1235
Placidi GF, Signoretta A, Liguori A, Gervasi R, Maremmani I, Akiskal HS (1998) The semi- structured affective temperament interview (TEMPS-I). Reliability and psychometric properties in 1010 14–26 year old students. J Affect Disord 47(1–3):1–10
Spitzer RL, Williams JBW, Gibbon M, First MB (eds) (1990) Structured Clinical Interview for DSM-III-R personality Disorders (SCID-II). Washington
Lecrubier Y, Judge R (1997) Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand 95(2):145–152
Perugi G, Toni C, Akiskal HS (1999) Anxious-bipolar comorbidity. Diagnostic and treatment challenges. Psychiatr Clin North Am 22(3):565–583
McElroy SL, Altshuler LL, Suppes T, Keck PEJ, Frye MA, Denicoff KD et al (2001) Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 158(3):420–426
Angst J, Gamma A, Endrass J, Hantouche E, Goodwin R, Ajdacic V et al (2005) Obsessive-compulsive syndromes and disorders: significance of comorbidity with bipolar and anxiety syndromes. Eur Arch Psychiatry Clin Neurosci 255(1):65–71
Angst J, Gamma A, Endrass J, Rossler W, Ajdacic-Gross V, Eich D et al (2006) Is the association of alcohol use disorders with major depressive disorder a consequence of undiagnosed bipolar-II disorder? Eur Arch Psychiatry Clin Neurosci 256(7):452–457
Endrass J, Vetter S, Gamma A, Gallo WT, Rossegger A, Urbaniok F et al (2007) Are behavioral problems in childhood and adolescence associated with bipolar disorder in early adulthood? Eur Arch Psychiatry Clin Neurosci 257(4):217–221
Zutshi A, Janardhan Reddy YC, Thennarasu K, Chandrashekhar CR (2006) Comorbidity of anxiety disorders in patients with remitted bipolar disorder. Eur Arch Psychiatry Clin Neurosci 256(7):428–436
Angst J, Gamma A, Benazzi F, Ajdacic V, Rossler W (2009) Does psychomotor agitation in major depressive episodes indicate bipolarity? Evidence from the Zurich Study. Eur Arch Psychiatry Clin Neurosci 259(1):55–63
Moller HJ (2008) The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European Psychiatric tradition. Eur Arch Psychiatry Clin Neurosci 258(5):7–17
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perugi, G., Frare, F., Toni, C. et al. Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year “open” follow-up study. Eur Arch Psychiatry Clin Neurosci 260, 553–560 (2010). https://doi.org/10.1007/s00406-010-0109-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-010-0109-y